By offering an extensive array of services, Cirrus Pharmaceuticals is contributing to the development of a wide range of pharmaceutical products. The services offered by our formulation development group include feasibility studies to assist in dosage form design, excipient compatibility studies to aid in selection of excipients, product/process optimization through batch manufacture, physicochemical testing, process scale-up, technology transfer and batch manufacture for GLP Tox support. Our scientists have experience formulating small molecules, peptides and proteins.
Cirrus scientists work closely with clients to ensure they are well prepared in advance for the regulatory submission process so that topics such as formulation optimization, scale-up feasibility, and product performance are well substantiated.
A wide variety of dosage forms can be developed at Cirrus, and our scientists work to develop novel technologies when requested. Dosage forms that can be developed at Cirrus include:
Formulations and optimizations are aided by the extensive use of statistical design of experiments.
The scientists at Cirrus have years of experience developing a wide range of dosage forms. With this experience they are well equipped to provide the following areas of expertise:
